Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

From RCPI news release:
"Dr. Mullan continued, "During the first quarter of 2015, we commenced our Phase I trial in the UK and began dosing in Part One of the study. We look forward to providing subsequent updates in the coming months regarding progress of the Phase I trial as we generate the first human clinical data with the prototype drugs being tested under this CTA. As previously announced, under our current development plan and contingent on obtaining sufficient capital resources, we plan on initiating one or more Phase IIa trials during the second half of 2015."

You can read complete release at:
http://investors.rockcreekpharmaceuticals.com/2015-03-12-Rock-Creek-Pharmaceuticals-Files-2014-Annual-Report-and-Provides-Clinical-Development-Update